URGN Earnings

Quarterly EPS
$-0.51
Q3 2024
$-0.80
Q4 2024
$-0.92
Q1 2025
$-1.05
Q2 2025
$-0.69
Q3 2025
$-0.54
Q4 2025
$-0.47
Q1 2026
$-0.28
Q2 2026
Latest Revenue72.5M
Latest Net Income-14351000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.2872.5M-14351000+199.2%+73.3%
Q1 2026-$0.4751.0M-23574000+151.6%+48.9%
Q4 2025-$0.5437.8M-26364000+54.0%+32.5%
Q3 2025-$0.6927.5M-33347000+9.0%-35.3%
Q2 2025-$1.0524.2M-49940000+10.8%-28.0%
Q1 2025-$0.9220.3M-43843000+7.8%-5.7%
Q4 2024-$0.8024.6M-37512000+4.4%-11.1%
Q3 2024-$0.5125.2M-23673000+20.9%+25.0%
Q2 2024-$0.8221.8M-33403000
Q1 2024-$0.8718.8M-32286000
Q4 2023-$0.7223.5M-26016000
Q3 2023-$0.6820.9M-21879000
UroGen Pharma (URGN) — Earnings